Li et al. Post menopausal bone loss: could probiotics help?

IBMS BoneKEy ◽  
2016 ◽  
Vol 13 ◽  
pp. 834
Keyword(s):  
Bone Loss ◽  
Post Menopausal

The archaeology of osteoporosis

2001 ◽  
Vol 4 (2) ◽  
pp. 263-269 ◽  
Author(s):  
Gordon Turner-Walker ◽  
Unni Syversen ◽  
Simon Mays
Keyword(s):  
Bone Loss ◽  
Femoral Neck ◽  
Young Women ◽  
Rapid Decline ◽  
Mineral Density ◽  
Medieval Women ◽  
Age Related ◽  
Pregnancy And Lactation ◽  
Post Menopausal ◽  
The Uk

The application of medical scanning technologies to archaeological skeletons provides novel insights into the history and potential causes of osteoporosis. The present study investigated bone mineral density (BMD) in medieval skeletons from England and Norway. Comparisons between the two adult populations found no statistically significant differences. This compares with a modern fracture incidence for the femoral neck in women from Norway that is almost three times that in the UK. The pattern of age-related bone loss in medieval men was similar to that seen in men today. In contrast, the pattern in medieval women differed from that of modern young women. On average, medieval women experienced a decrease in BMD at the femoral neck of approximately 23 per cent between the ages of 22 and 35. These losses were partially recovered by age 45, after which BMD values show a decline consistent with post-menopausal bone loss in modern western women. A possible explanation of the rapid decline in BMD in young medieval women is bone loss in connection with pregnancy and lactation in circumstances of insufficient nutrition.

scholarly journals Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women

2012 ◽  
Vol 20 (5) ◽  
pp. 559-564 ◽  
Author(s):  
Alison Gartland ◽  
Kristen K Skarratt ◽  
Lynne J Hocking ◽  
Claire Parsons ◽  
Leanne Stokes ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Lumbar Spine ◽  
Bone Loss ◽  
Bone Mineral ◽  
P2x7 Receptor ◽  
Receptor Gene ◽  
Spine Bone Mineral Density ◽  
Mineral Density ◽  
Menopausal Women ◽  
Post Menopausal

Prevention of post-menopausal bone loss with 1α-hydroxy vitamin D3 a three-year prospective study

1992 ◽  
Vol 11 (4) ◽  
pp. 492-497 ◽  
Author(s):  
J. M. Pouilles ◽  
F. Tremollieres ◽  
C. Ribot
Keyword(s):  
Bone Loss ◽  
Prospective Study ◽  
Vitamin D3 ◽  
Post Menopausal

Prevention of post-menopausal bone loss with transdermal estrogen: analysis of individual bone density changes

1996 ◽  
Vol 6 (S1) ◽  
pp. 227-227
Author(s):  
R. Bakshi ◽  
D. Serrurier ◽  
A-M. Vigneron ◽  
T. Darragon ◽  
M. Audran
Keyword(s):  
Bone Density ◽  
Bone Loss ◽  
Transdermal Estrogen ◽  
Post Menopausal

Dietary determinants of post-menopausal bone loss at the lumbar spine: a possible beneficial effect of iron

2006 ◽  
Vol 17 (8) ◽  
pp. 1165-1173 ◽  
Author(s):  
R. Abraham ◽  
J. Walton ◽  
L. Russell ◽  
R. Wolman ◽  
B. Wardley-Smith ◽  
...  
Keyword(s):  
Lumbar Spine ◽  
Bone Loss ◽  
Beneficial Effect ◽  
Post Menopausal

Potential Application of Low-Dose Doxycycline to Treat Periodontitis in Post-Menopausal Women

1998 ◽  
Vol 12 (1) ◽  
pp. 166-169 ◽  
Author(s):  
J.B. Payne ◽  
R.A. Reinhardt
Keyword(s):  
Bone Loss ◽  
Tooth Loss ◽  
Low Dose ◽  
Alveolar Bone ◽  
Public Health Problem ◽  
The United States ◽  
Alveolar Bone Loss ◽  
Design Concepts ◽  
Significant Public Health ◽  
Post Menopausal

The purpose of this paper is two-fold: (1) to review the evidence that osteoporosis and post-menopausal estrogen deficiency are associated with progressive alveolar bone loss and an elevated risk of tooth loss; and (2) to propose the use of tetracyclines, specifically low-dose doxycycline (LDD) (and, perhaps in the future, the chemically modified tetracyclines), to mitigate alveolar bone loss in post-menopausal osteoporotic/osteopenic women. Design concepts for a randomized clinical trial to study the effects of LDD on progressive alveolar bone loss in this patient population are reviewed. Since osteoporosis affects over 20 million people in the United States, progressive alveolar bone loss in this patient group represents a potentially significant public health problem unique from common adult periodontitis. Stopping progressive alveolar bone loss is essential to prevent both tooth loss and micro-architectural deterioration of alveolar bone.

Cytokines and T-lymphocyte subsets in healthy post-menopausal women: Estrogen retards bone loss without affecting the release of IL-1 or IL-1ra

Bone ◽  
1997 ◽  
Vol 20 (3) ◽  
pp. 251-258 ◽  
Author(s):  
B. Abrahamsen ◽  
K. Bendtzen ◽  
H. Beck-Nielsen
Keyword(s):  
Bone Loss ◽  
T Lymphocyte ◽  
Lymphocyte Subsets ◽  
T Lymphocyte Subsets ◽  
Menopausal Women ◽  
Post Menopausal

P27 Oral Didronel in the prevention of post menopausal bone loss

Bone ◽  
1992 ◽  
Vol 13 (3) ◽  
pp. 281
Author(s):  
D.A. Heath ◽  
B. Walters
Keyword(s):  
Bone Loss ◽  
Post Menopausal
Sign in / Sign up

Export Citation Format

Share Document